MarketCap
Facebook
X
TelegramQuarterly report 2023-Q1
added 05-10-2023
Country |
 USA |
IPO year |
2014 |
Industry |
Diagnostics research |
Stock Exchange |
NASDAQ GLOBALSPB |
Shares |
104 M |
Market Cap[1] |
$ 4.46 B |
EBITDA (LTM) |
$ 391 M |
P/E (LTM) |
- |
P/S (LTM) |
0.84 |
EPS (LTM) |
0.91 |
Other stocks of industry "Diagnostics research"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
- | -6.23 % | $ 30.6 M | Nasdaq Global Market |  Germany |
 |
Bioventus
BVS
|
$ 9.25 | -0.11 % | $ 616 M | Nasdaq Global Select Market | USA |
|
Biodesix
BDSX
|
$ 14.56 | -0.27 % | $ 1.89 B | Nasdaq Global Market | USA |
 |
DarioHealth Corp.
DRIO
|
$ 8.45 | - | $ 33.7 M | Nasdaq Capital Market |  Israel |
 |
Enzo Biochem
ENZ
|
- | -8.98 % | $ 14.8 K | NYSE | USA |
 |
Exact Sciences Corporation
EXAS
|
- | - | $ 19.8 B | Nasdaq Capital Market,SPB | USA |
|
Akumin
AKU
|
- | -17.87 % | $ 25.9 M | Nasdaq Capital Market |  Canada |
 |
Check-Cap Ltd.
CHEK
|
- | - | $ 9.42 M | Nasdaq Capital Market | Israel |
 |
Heska Corporation
HSKA
|
- | - | $ 1.31 B | Nasdaq Capital Market,SPB | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
- | - | $ 562 M | Nasdaq Global Select Market |  Britain |
 |
IDEXX Laboratories
IDXX
|
$ 566.57 | -1.17 % | $ 45.6 B | Nasdaq Global Select Market,SPB | USA |
 |
Medpace Holdings
MEDP
|
$ 462.67 | -0.84 % | $ 13.3 B | Nasdaq Global Select Market,SPB | USA |
 |
Illumina
ILMN
|
$ 121.35 | -2.45 % | $ 19.3 B | Nasdaq Global Select Market,SPB | USA |
 |
Trinity Biotech plc
TRIB
|
$ 0.62 | 1.06 % | $ 61.9 M | Nasdaq Global Select Market |  Irlanda |
 |
DermTech
DMTK
|
- | -11.32 % | $ 2.94 M | Nasdaq Capital Market,SPB | USA |
 |
Aspira Women's Health
AWH
|
- | -6.19 % | $ 10.5 M | Nasdaq Capital Market,SPB | USA |
 |
Co-Diagnostics
CODX
|
$ 4.4 | 101.83 % | $ 129 M | Nasdaq Capital Market | USA |
 |
Accelerate Diagnostics
AXDX
|
- | -61.36 % | $ 2.46 M | Nasdaq Global Select Market | USA |
 |
OPKO Health
OPK
|
$ 1.14 | -2.44 % | $ 791 M | Nasdaq Global Select Market | USA |
 |
Global Cord Blood Corporation
CO
|
- | - | $ 399 M | NYSE |  China |
 |
Fluidigm Corporation
FLDM
|
- | 1.08 % | $ 308 M | Nasdaq Global Select Market | USA |
 |
Genetic Technologies Limited
GENE
|
- | - | $ 7.1 B | Nasdaq Capital Market |  Australia |
 |
Genetron Holdings Limited
GTH
|
- | 0.12 % | $ 80.1 M | Nasdaq Global Market | China |
 |
National Research Corporation
NRC
|
$ 16.93 | -2.48 % | $ 379 M | Nasdaq Global Select Market | USA |
 |
HTG Molecular Diagnostics
HTGM
|
- | -20.0 % | $ 1.06 M | Nasdaq Capital Market | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
- | - | $ 10.7 B | Nasdaq Global Select Market | USA |
 |
VolitionRx Limited
VNRX
|
$ 0.19 | -3.63 % | $ 18.3 M | NYSE American |  Singapore |
 |
Charles River Laboratories International
CRL
|
$ 160.77 | -2.64 % | $ 7.97 B | NYSE,SPB | USA |
 |
Organovo Holdings
ONVO
|
- | -2.3 % | $ 19.4 M | Nasdaq Capital Market | USA |
 |
OpGen
OPGN
|
- | -16.95 % | $ 1.54 M | Nasdaq Capital Market | USA |
 |
Waters Corporation
WAT
|
$ 295.27 | -1.76 % | $ 17.6 B | NYSE,SPB | USA |
 |
Biocept
BIOC
|
- | -13.05 % | $ 7.29 M | Nasdaq Capital Market | USA |
 |
ENDRA Life Sciences
NDRA
|
$ 4.79 | 6.32 % | $ 2.57 M | Nasdaq Global Select Market | USA |
 |
PerkinElmer
PKI
|
- | -0.91 % | $ 14.7 B | NYSE,SPB | USA |
 |
Invitae Corporation
NVTA
|
- | - | $ 21.2 M | NYSE,SPB | USA |
 |
Exagen
XGN
|
$ 2.71 | -2.87 % | $ 58.4 M | Nasdaq Global Market | USA |
 |
Interpace Biosciences
IDXG
|
$ 1.73 | 2.37 % | $ 7.59 M | Nasdaq Global Select Market | USA |
 |
Soleno Therapeutics
SLNO
|
$ 31.12 | -2.23 % | $ 1.58 B | Nasdaq Capital Market | USA |
 |
RadNet
RDNT
|
$ 57.9 | -2.54 % | $ 4.35 B | Nasdaq Global Select Market | USA |
 |
Motus GI Holdings
MOTS
|
- | -34.28 % | $ 263 K | Nasdaq Global Select Market | Israel |
 |
QIAGEN N.V.
QGEN
|
- | - | $ 10.6 B | NYSE |  Niderland |
 |
Thermo Fisher Scientific
TMO
|
$ 482.91 | -1.22 % | $ 182 B | NYSE,SPB | USA |
 |
Celcuity
CELC
|
$ 114.04 | -0.67 % | $ 5.33 B | Nasdaq Global Select Market | USA |
 |
Chembio Diagnostics
CEMI
|
- | 0.22 % | $ 16.8 M | Nasdaq Capital Market | USA |
 |
Senseonics Holdings
SENS
|
$ 6.53 | -0.53 % | $ 272 M | NYSE American | USA |
 |
Laboratory Corporation of America Holdings
LH
|
$ 265.93 | -0.91 % | $ 22.1 B | NYSE,SPB | USA |
 |
NeoGenomics
NEO
|
$ 7.58 | -2.32 % | $ 971 M | Nasdaq Global Select Market,SPB | USA |
 |
Psychemedics Corporation
PMD
|
- | -1.84 % | $ 15.3 M | Nasdaq Global Select Market | USA |
 |
Precipio
PRPO
|
$ 26.54 | -2.43 % | $ 34.4 M | Nasdaq Global Select Market | USA |
 |
CareDx, Inc
CDNA
|
$ 17.22 | -1.43 % | $ 918 M | Nasdaq Global Market,SPB | USA |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.